EmpiraMed Inc is a digital health technology company based in Maynard, MA that specializes in generating Real World Evidence for the Life Science Industry through post-market, prospective, Virtual Clinical Studies. Their innovative software and patient-engagement platform allow for the evaluation of real-time patient experience, optimization of reimbursement based on comparative effectiveness, monitoring of treatment safety, and the development of treatment best practices for unmet needs. With their integrated approach that combines patient reported outcomes (PROs) with clinical information from electronic medical records (EMRs), EmpiraMed provides a holistic view of patient care and aims to improve health outcomes and reduce costs.
EmpiraMed's decentralized study platform offers novel patient recruitment channels, direct-to-patient data capture software, and a patient incentivization system to automate study tasks. Their 360-degree view of the patient includes integration with electronic health records (EHRs), pharmacy data, and claims data, allowing for a comprehensive understanding of treatments and patient response. By conducting site-less trials, EmpiraMed aims to expand patient access, reduce costs, and shorten time to market, ultimately improving the success rate of clinical studies in the Life Science Industry.
Generated from the website
